Is topical monotherapy effective for localized pyoderma gangrenosum?
Department of Dermatology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France. laurence.lecleach@free.fr
Laurence
L
Le Cleach
Philippe
P
Moguelet
Pascal
P
Perrin
Olivier
O
Chosidow
D000279:Administration, Cutaneous; D000328:Adult; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000473:pathology; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016559:Tacrolimus